TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Beximco Pharmaceuticals Limited Sponsored GDR RegS ( (GB:BXP) ) just unveiled an update.
Beximco Pharmaceuticals Limited has provided an update regarding the Bangladesh Securities and Exchange Commission’s proposal to appoint nine additional independent non-executive directors to its Board. The High Court hearing on this matter is ongoing, with a decision expected by the end of June, following further hearings. This development could impact the company’s governance structure, potentially influencing its strategic direction and stakeholder relations.
More about Beximco Pharmaceuticals Limited Sponsored GDR RegS
Beximco Pharmaceuticals Limited is a leading manufacturer and exporter of generic pharmaceutical products and active pharmaceutical ingredients based in Bangladesh. Established in 1976, the company offers a broad portfolio of generics, including tablets, capsules, liquids, and more, serving over 50 countries with state-of-the-art manufacturing facilities certified by global regulatory authorities. Beximco Pharma also engages in contract manufacturing for multinational and global generic pharmaceutical companies.
Average Trading Volume: 41,997
Technical Sentiment Signal: Strong Sell
Learn more about BXP stock on TipRanks’ Stock Analysis page.